The report also identifies the most significant strategies that pharmaceutical industry suppliers plan to implement. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and size.

Scope

• The opinions and forward looking statements of XXXX industry executives have been captured in our in-depth survey, of which XX% represent Director and C-level respondents.

• The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations.

• The geographical scope of the research is global – drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific, Africa and Middle East.

• Covers data and analysis on supplier expenditure, sales and marketing and industry developments.

• Provides insights into the marketing needs of pharmaceutical industry suppliers and how they are looking to develop their marketing and sales strategies in the future.

• Examines current practices and provides future expectations for the industry over the next 12-24 months.

Reasons to buy

•    Drive revenues by understanding future product investment areas and growth regions.

•    Formulate effective sales and marketing strategies by identifying how buyer budgets are changing and the direction of spend in the future.

•    Better promote your business by aligning your capabilities and business practices with your customer’s changing needs.

•    Secure stronger customer relationships by understanding the leading business concerns and changing strategies of industry buyers.
•    Predict how the industry will grow, consolidate and where it will stagnate.

•    Uncover the business outlook, key challenges and opportunities identified by suppliers.

•    Analysis of opinions drawn from leading pharmaceutical industry executives

•    Identifies and analyzes the key marketing and sales strategies companies will be adopting to deal with market conditions in 2011–2012

To purchase this detailed report, please click here.